Magnolia
Vreeland, Niederlande
Behandlung & Zugang
- Angebotene Behandlungenesketamine (Spravato)
- ZugangswegDurch ein nationales Programm übernommen
- Kosten & Übernahme (Registerstatus)Reimbursed via Dutch basic health insurance (esketamine nasal spray for TRD)
- ErstattungMember of Esketamine Neusspray Consortium (ENC-NL); esketamine covered per ENC-NL protocol So funktioniert die Erstattung in Europa →
- Telefon+31 85 212 7736
- Websitehttps://therapy.mymagnolia.nl/programma-met-esketamine-neusspray-spravato/
Über diesen Anbieter
Magnolia Therapy in Vreeland is a non-contracted specialist GGZ provider offering a roughly six-month esketamine nasal spray (Spravato) programme for adults (18+) with treatment-resistant depression: insufficient response to at least two antidepressants in adequate dose and duration plus at least one augmentation strategy, with a concurrent oral antidepressant during treatment. A multidisciplinary team of psychiatrists, physicians, psychologists and nurses delivers the programme. Typically there are two esketamine sessions per week in the first four weeks, tapering to weekly or fortnightly, with monthly psychiatrist consults in the start phase and optional additional psychotherapy (CBT, ACT, psychodynamic therapy, IPT) where indicated. A referral from a treating physician and prior insurer authorisation are required before the programme can start; Magnolia states treatment can start without waiting lists.
Leistungen & Programme
- Esketamine nasal spray (Spravato) programme for treatment-resistant depression, approximately six months, with administration under medical supervision on site
- Programme with racemic ketamine (intramuscular, optional intervention) — a shorter intensive course of around six weeks
- Psychiatric follow-up including monthly psychiatrist consults in the start phase
- Optional additional psychotherapy where indicated: CBT, ACT, psychodynamic therapy, interpersonal therapy (IPT)
Preise
| Leistung | Preis |
|---|---|
| Screening | Free of charge (the insurer's reimbursement for the screening is passed on to Magnolia) |
| Esketamine nasal spray medication | Fully reimbursed by the health insurer after an approved authorisation |
| Own contribution per esketamine treatment session | EUR 50 per session (in addition to the insurer's reimbursement) |
| Own contribution for the monthly psychiatrist consult | EUR 50 per month (in addition to the insurer's reimbursement) |
| Average total own contribution | Approximately EUR 215 per month for a course of about 20 treatments over 6 months; can be lower if fewer treatments are needed |
Häufige Fragen
Do I need a referral or authorisation?
Yes. A referral to specialist GGZ from a treating physician or therapist is required. For the esketamine nasal spray programme, prior authorisation from your health insurer is also required before the programme can start; Magnolia guides you through this process.
Who qualifies for the esketamine programme?
Adults (18+) diagnosed with treatment-resistant depression: insufficient response to at least two different antidepressants in adequate dose and duration, plus at least one augmentation strategy without sufficient effect. During the esketamine treatment you use an oral antidepressant as prescribed by your treating physician.
What does a session look like?
Administration takes place in a specially designed, quiet treatment setting. You wear an eye mask and listen to selected music; there is continuous guidance and monitoring, and observation after the session before you go home. No medication is given to take home.
How often and how long is the treatment?
In most cases two esketamine treatments per week during the first four weeks, then tapering to once a week or once every two weeks depending on clinical response. The esketamine programme is a six-month course; the standard protocol is around 20 treatments, adjusted to your personal situation.
Verifizierung
- Lizenz / RegisterENC-NL
- Quellehttps://enc-nl.nl/
- Zuletzt verifiziert